156 related articles for article (PubMed ID: 10915930)
1. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.
Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG
Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493
[TBL] [Abstract][Full Text] [Related]
3. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
4. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
Silley P; Monsey D; Harris AM
J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
Brink HS; Huisman RM; Geerlings W; de Jong PE
Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
[TBL] [Abstract][Full Text] [Related]
8. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.
Zhao LS; Yin R; Wei BB; Li Q; Jiang ZY; Chen XH; Bi KS
Acta Pharmacol Sin; 2012 Nov; 33(11):1348-52. PubMed ID: 23064723
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
[TBL] [Abstract][Full Text] [Related]
11. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
13. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
[TBL] [Abstract][Full Text] [Related]
16. Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats.
González-Hernández I; Jung-Cook H; Sotelo A
J Pharm Pharm Sci; 2008; 11(1):9-21. PubMed ID: 18445361
[TBL] [Abstract][Full Text] [Related]
17. Effect of food on pharmacokinetics of cefuroxime axetil in Chinese subjects.
Chen RR; Lee TY; Hsieh WC
J Formos Med Assoc; 1992 Dec; 91(12):1177-81. PubMed ID: 1363640
[TBL] [Abstract][Full Text] [Related]
18. Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil.
Haddad J; Isaacson G; Respler DS; Hart RW; Yilmaz HM; Collins JJ; Bluestone CD
Pediatr Infect Dis J; 1991 Apr; 10(4):294-8. PubMed ID: 2062625
[TBL] [Abstract][Full Text] [Related]
19. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
[TBL] [Abstract][Full Text] [Related]
20. The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.
Williams PE; Harding SM
J Antimicrob Chemother; 1984 Feb; 13(2):191-6. PubMed ID: 6706890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]